25 results
8-K
EX-99.2
ELTX
Elicio Therapeutics Inc.
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
, complete clinical trials for, obtain approvals for and commercialize any of our product candidates, including our ability to recruit and enroll
8-K
EX-99.2
ELTX
Elicio Therapeutics Inc.
27 Sep 23
Other Events
5:41pm
, complete clinical trials for, obtain approvals for and commercialize any of our product candidates, including our ability to recruit and enroll patients
8-K
EX-99.4
yxn3bi2s8ahm k35p
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.3
8zpodx wrpd83w
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
2h5jrrpq
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
EX-10.29
plwkdrwhbcyws 46y
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
nz92t1 ctgtke2ie12l
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
10-Q
rjf 8zypgnb9b4v7w
17 May 21
Quarterly report
6:03am
10-K
54oljfdgxw3t pfa7w
30 Mar 21
Annual report
5:00pm
424B4
qwk ud715r5
5 Feb 21
Prospectus supplement with pricing info
5:12pm